BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24141534)

  • 1. Investigating intratumour heterogeneity by single-cell sequencing.
    Ren SC; Qu M; Sun YH
    Asian J Androl; 2013 Nov; 15(6):729-34. PubMed ID: 24141534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour heterogeneity in the clinic.
    Bedard PL; Hansen AR; Ratain MJ; Siu LL
    Nature; 2013 Sep; 501(7467):355-64. PubMed ID: 24048068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour heterogeneity and cancer cell plasticity.
    Meacham CE; Morrison SJ
    Nature; 2013 Sep; 501(7467):328-37. PubMed ID: 24048065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of single cell heterogeneity in cancer.
    Qian M; Wang DC; Chen H; Cheng Y
    Semin Cell Dev Biol; 2017 Apr; 64():143-149. PubMed ID: 27619166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Progresses of Single Cell DNA Sequencing in Breast Cancer Research.
    Liu J; Adhav R; Xu X
    Int J Biol Sci; 2017; 13(8):949-960. PubMed ID: 28924377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constraints in cancer evolution.
    Venkatesan S; Birkbak NJ; Swanton C
    Biochem Soc Trans; 2017 Feb; 45(1):1-13. PubMed ID: 28202655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Cell Sequencing in Genitourinary Malignancies.
    Murphy N; Shah P; Shih A; Khalili H; Liew A; Zhu X; Lee A
    Adv Exp Med Biol; 2020; 1255():153-164. PubMed ID: 32949398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Applications of and Challenges in Single-Cell Analysis of Circulating Tumor Cells.
    Wu CP; Wu P; Zhao HF; Liu WL; Li WP
    DNA Cell Biol; 2018 Feb; 37(2):78-89. PubMed ID: 29265876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.
    Caswell DR; Swanton C
    BMC Med; 2017 Jul; 15(1):133. PubMed ID: 28716075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics roadmap for therapy selection in cancer genomics.
    Jiménez-Santos MJ; García-Martín S; Fustero-Torre C; Di Domenico T; Gómez-López G; Al-Shahrour F
    Mol Oncol; 2022 Nov; 16(21):3881-3908. PubMed ID: 35811332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells: a guide for skeptics.
    Tomasson MH
    J Cell Biochem; 2009 Apr; 106(5):745-9. PubMed ID: 19184979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the dynamic cancer stem cell model: Importance of tumour edges.
    Hernández-Camarero P; Jiménez G; López-Ruiz E; Barungi S; Marchal JA; Perán M
    Crit Rev Oncol Hematol; 2018 Nov; 131():35-45. PubMed ID: 30293704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumour heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification: a descriptive study.
    Cuevas D; Velasco A; Vaquero M; Santacana M; Gatius S; Eritja N; Estaran E; Matias-Guiu X
    Histopathology; 2020 Feb; 76(3):447-460. PubMed ID: 31550396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-tumor heterogeneity from a cancer stem cell perspective.
    Prasetyanti PR; Medema JP
    Mol Cancer; 2017 Feb; 16(1):41. PubMed ID: 28209166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers.
    Bowes AL; Tarabichi M; Pillay N; Van Loo P
    J Pathol; 2022 Jul; 257(4):466-478. PubMed ID: 35438189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis.
    Tellez-Gabriel M; Ory B; Lamoureux F; Heymann MF; Heymann D
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing genetic markers of tumour progression in the context of intratumour heterogeneity.
    Chapman JA; Wolman E; Wolman SR; Remvikos Y; Shackney S; Axelrod DE; Baisch H; Christensen IJ; White RA; Liebovitch LS; Moore DH; Waldman FM; Cornelisse CJ; Shankey TV
    Cytometry; 1998 Jan; 31(1):67-73. PubMed ID: 9450527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roots of cancer: stem cells and the basis for tumor heterogeneity.
    Shibata M; Shen MM
    Bioessays; 2013 Mar; 35(3):253-60. PubMed ID: 23027425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.